Tilray expands medical cannabis portfolio in Germany with new craft products (NASDAQ:TLRY)

Tilray Medical, a division of Tilray Brands (NASDAQ:TLRY), has launched five new cannabis flower products in Germany under its Tilray Craft line.

The products are cultivated at Tilray’s EU-GMP certified facility in Neumünster, Germany, as part of the BfArM in-country cultivation program.

The new strains include high-THC varieties: THC30 TRM (Triangle Mints),  THC28 TRM (Triangle Mints), THC28 PPV (Platinum Pave 34), THC25 PPV (Platinum Pave 34) and THC22 SNS (Sunset Sherbet).

All products are available by prescription in German pharmacies.

TLRY shares down 5.4% premarket on Tuesday. 

Source: Press release